LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 513 | 841 | 10401 | 0.0809 | 0.0331 |
MCF 10A | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 513 | 9694 | 10401 | 0.9320 | 0.9285 |
MCF 10A | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 9609 | 10401 | 0.9239 | 0.9199 |
MCF 10A | XL147 | 0.37 | uM | LJP5 | 72 | hr | 513 | 9954 | 10401 | 0.9570 | 0.9548 |
MCF 10A | Saracatinib | 0.37 | uM | LJP6 | 72 | hr | 513 | 7574 | 10401 | 0.7282 | 0.7141 |
MCF 10A | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 513 | 1629 | 10401 | 0.1567 | 0.1129 |
MCF 10A | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 513 | 10033 | 10401 | 0.9647 | 0.9628 |
MCF 10A | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 513 | 10330 | 10401 | 0.9932 | 0.9928 |
MCF 10A | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 513 | 9431 | 10401 | 0.9067 | 0.9019 |
MCF 10A | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 9475 | 10401 | 0.9110 | 0.9064 |
MCF 10A | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 513 | 9094 | 10401 | 0.8743 | 0.8678 |
MCF 10A | Torin1 | 0.37 | uM | LJP6 | 72 | hr | 513 | 1114 | 10401 | 0.1071 | 0.0608 |
MCF 10A | Torin2 | 0.37 | uM | LJP5 | 72 | hr | 513 | 472 | 10401 | 0.0454 | -0.0042 |
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 513 | 1079 | 10401 | 0.1038 | 0.0572 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 737 | 10401 | 0.0709 | 0.0226 |
MCF 10A | TWS119 | 0.37 | uM | LJP5 | 72 | hr | 513 | 10898 | 10401 | 1.0478 | 1.0502 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 513 | 9959 | 10401 | 0.9576 | 0.9554 |
MCF 10A | Withaferin A | 0.37 | uM | LJP5 | 72 | hr | 513 | 7214 | 10401 | 0.6936 | 0.6777 |
MCF 10A | Withaferin A | 0.37 | uM | LJP6 | 72 | hr | 513 | 6298 | 10401 | 0.6055 | 0.5850 |
MCF 10A | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 513 | 1303 | 10401 | 0.1253 | 0.0799 |
MCF 10A | WZ3105 | 0.37 | uM | LJP5 | 72 | hr | 513 | 678 | 10401 | 0.0652 | 0.0167 |
MCF 10A | XMD11-50 | 0.37 | uM | LJP6 | 72 | hr | 513 | 7006 | 10401 | 0.6736 | 0.6567 |
MCF 10A | Y39983 | 0.37 | uM | LJP6 | 72 | hr | 513 | 7611 | 10401 | 0.7318 | 0.7178 |
MCF 10A | YM 201636 | 0.37 | uM | LJP5 | 72 | hr | 513 | 8987 | 10401 | 0.8641 | 0.8571 |
MCF 10A | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 513 | 3122 | 10401 | 0.3002 | 0.2638 |